Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2017 Mar-2016 Mar-2015 Mar-2014
Growth matrix (%)        
Revenue growth 22.60 (6.60) 1.21 --
Op profit growth (26) 99.90 (40) --
EBIT growth (31) 7,946 (105) --
Net profit growth (86) (590) (73) --
Profitability ratios (%)        
OPM 7.73 12.70 5.95 9.99
EBIT margin 11.70 20.90 0.24 (5)
Net profit margin 1.42 12.80 (2.40) (9.10)
RoCE (28) 224 2.86 --
RoNW 0.25 1.90 (0.40) --
RoA 0.21 1.47 (0.30) --
Per share ratios ()        
EPS 0.44 3.25 -- --
Dividend per share -- -- -- --
Cash EPS (0.90) 2.86 (3.50) (6.80)
Book value per share 44.80 44.40 41.10 42
Valuation ratios        
P/E 91.80 11.80 -- --
P/CEPS (46) 13.40 (3.10) (1.50)
P/B 0.90 0.86 0.27 0.23
EV/EBIDTA 5.64 5.66 (3.30) 5.32
Payout (%)        
Dividend payout -- -- -- --
Tax payout (49) (30) (84) 4.11
Liquidity ratios        
Debtor days 176 200 142 --
Inventory days 77.90 76.70 65.20 --
Creditor days (98) (108) (67) --
Leverage ratios        
Interest coverage (4.50) (7.70) (0.10) 1.33
Net debt / equity (0.30) (0.10) (0.50) 0.14
Net debt / op. profit (5.10) (1.80) (13) 2.21
Cost breakup ()        
Material costs (59) (52) (63) (57)
Employee costs (13) (13) (13) (14)
Other costs (20) (22) (18) (19)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2017 Mar-2016 Mar-2015 Mar-2014
Revenue 65.70 53.60 57.40 56.70
yoy growth (%) 22.60 (6.60) 1.21 --
Raw materials (39) (28) (36) (32)
As % of sales 58.80 52 62.90 56.60
Employee costs (8.70) (7.20) (7.60) (8)
As % of sales 13.20 13.40 13.30 14
Other costs (13) (12) (10) (11)
As % of sales 20.30 21.80 17.90 19.40
Operating profit 5.08 6.83 3.42 5.66
OPM 7.73 12.70 5.95 9.99
Depreciation (2.80) (0.80) (6.10) (9.10)
Interest expense (1.70) (1.40) (1.70) (2.10)
Other income 5.39 5.18 2.79 0.57
Profit before tax 5.98 9.74 (1.60) (5)
Taxes (2.90) (2.90) 1.31 (0.20)
Tax rate (49) (30) (84) 4.11
Minorities and other -- -- -- --
Adj. profit 3.05 6.85 (0.20) (5.20)
Exceptional items (2.10) -- (1.10) --
Net profit 0.93 6.85 (1.40) (5.20)
yoy growth (%) (86) (590) (73) --
NPM 1.42 12.80 (2.40) (9.10)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2017 Mar-2016 Mar-2015 Mar-2014
Profit before tax 5.98 9.74 (1.60) (5)
Depreciation (2.80) (0.80) (6.10) (9.10)
Tax paid (2.90) (2.90) 1.31 (0.20)
Working capital 36.30 (9.30) 9.26 --
Other operating items -- -- -- --
Operating cashflow 36.60 (3.20) 2.94 --
Capital expenditure (66) 10.70 (11) --
Free cash flow (29) 7.44 (7.70) --
Equity raised 140 131 139 --
Investments 17 2.06 (2.10) --
Debt financing/disposal (13) (4.30) 4.34 --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 114 136 134 --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2017 Mar-2016 Mar-2015 Mar-2014
Equity capital 21 21 21 21
Preference capital -- -- -- --
Reserves 73.30 72.40 65.50 67.30
Net worth 94.30 93.40 86.60 88.30
Minority interest
Debt 9.72 24.20 28.60 23
Deferred tax liabilities (net) -- -- -- 1.40
Total liabilities 104 118 115 113
Fixed assets 11.30 14.70 4.87 73.10
Intangible assets
Investments 17 12.20 10.10 --
Deferred tax asset (net) 0.16 0.05 0.09 --
Net working capital 39.90 54.20 27.90 29.10
Inventories 13 15 7.52 13
Inventory Days 72.50 102 47.80 83.70
Sundry debtors 29.20 34.30 24.50 20.10
Debtor days 162 234 156 129
Other current assets 19.10 31.50 9.12 10.10
Sundry creditors (14) (19) (9) (11)
Creditor days 76.60 127 57.40 69.10
Other current liabilities (7.50) (8) (4.20) (3.30)
Cash 35.70 36.60 72.10 10.50
Total assets 104 118 115 113
Switch to
Consolidated
Standalone


Alpa Laboratories Ltd Report not showing data